OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

This study has been completed.

Study NCT00036647 Information provided by OSI Pharmaceuticals

First Received: May 13, 2002 Last Updated: November 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2003
Estimated Primary Completion Date:	No date given